Scholars Central

Review articlePublished 2018

Some Specific Regulatory Aspects and Nuances of Drug Products Localization in the Russian Federation

Authors: Anna Soltitskaya

Journal of Pharmacovigilance

Volume 6 · Issue 3 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Some important things you should know about drug products localization regulations in Russia. Brief overview of the main local regulations and factual law-enforcement practices that have an impact on your drug products localization projects. According to the Russian Government Decree, № 1289 dated by Nov. 30, 2015 “On limitations of drug products manufactured by foreign manufacturers as participants of Government Procurement” (so called rule “The third wheel”): if two applications at least for the Russian products are submitted, so any third application from some foreign manufacturer (not the Russian product) cannot be accepted. The Russian Federal Law 61 FZ “On drugs circulation” is the basic general legislation Act that regulates Drugs (DP & API) circulation (research & developing, clinical trials, manufacturing, expertise and registration, supply, sale, marketing etc.)

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacovigilance.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Anna Soltitskaya”